US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 2.2000
- +0.1050+5.01%
Close May 1 16:00 ET
- 2.1650
- -0.0350-1.59%
Post 17:36 ET
19.21MMarket Cap-1132P/E (TTM)
2.2790High2.0552Low52.35KVolume2.0600Open2.0950Pre Close113.14KTurnover0.66%Turnover RatioLossP/E (Static)8.73MShares5.410052wk High1.68P/B17.42MFloat Cap1.550052wk Low--Dividend TTM7.92MShs Float51.5000Historical High--Div YieldTTM10.68%Amplitude1.5500Historical Low2.1610Avg Price1Lot Size
Alterity Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -62.40%-20.04M | 28.81%-12.34M | ||||||||
| Net income from continuing operations | ---- | ---- | -7.47%-13.81M | ---- | ---- | ---- | ---- | 16.08%-12.85M | ---- | ---- |
| Operating gains losses | ---- | ---- | 67.39%-917.65K | ---- | ---- | ---- | ---- | -759.27%-2.81M | ---- | ---- |
| Depreciation and amortization | ---- | ---- | 88.63%102.26K | ---- | ---- | ---- | ---- | -28.07%54.21K | ---- | ---- |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 142.07%61 | ---- | ---- |
| Change In working capital | ---- | ---- | -462.49%-6.39M | ---- | ---- | ---- | ---- | 140.00%1.76M | ---- | ---- |
| -Change in receivables | ---- | ---- | -780.16%-3.94M | ---- | ---- | ---- | ---- | 89.38%-447.68K | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | -159.94%-1.56M | ---- | ---- | ---- | ---- | 501.52%2.6M | ---- | ---- |
| -Change in other current assets | ---- | ---- | -87.57%-968.21K | ---- | ---- | ---- | ---- | 0.28%-516.18K | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Change in other working capital | ---- | ---- | -35.97%78.69K | ---- | ---- | ---- | ---- | 215.47%122.88K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---- | ---- | -62.40%-20.04M | ---- | ---- | ---- | ---- | 28.81%-12.34M | ---- | ---- |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 79.50%-1K | -4K | 59.10%-36.46K | 70.18%-26.58K | -5K | -90.58%-4.88K | 0 | -751.29%-89.15K | -751.53%-89.15K | 0 |
| Net PPE purchase and sale | 79.50%-1K | ---4K | 91.80%-7.31K | 102.88%2.57K | ---5K | -90.58%-4.88K | --0 | -751.29%-89.15K | -751.53%-89.15K | --0 |
| Net intangibles purchase and sale | --0 | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 |
| Net business purchase and sale | --0 | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 |
| Net investment purchase and sale | --0 | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 |
| Net other investing changes | ---- | ---- | ---29.15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 79.50%-1K | ---4K | 59.10%-36.46K | 70.18%-26.58K | ---5K | -90.58%-4.88K | --0 | -751.29%-89.15K | -751.53%-89.15K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 990.74%970K | -114.05%-17K | -99.24%124.34K | 95.53%-12.76K | 12,400.00%125K | 59.51%-108.9K | -99.27%121K | -55.56%16.3M | -100.78%-285.44K | -59.17%1K |
| Net issuance payments of debt | --0 | --0 | -73.62%-59.92K | 6.84%-32.15K | --0 | -16.89%-27.77K | --0 | 40.79%-34.51K | 40.79%-34.51K | --0 |
| Net common stock issuance | 712,758.23%1.13M | --0 | -98.16%316.68K | 14,482.50%5.83K | --182K | -495.00%-158 | -99.25%129K | -56.22%17.18M | -100.00%40 | --0 |
| Cash dividends paid | --0 | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 |
| Net other financing activities | -92.66%-156K | -112.50%-17K | 84.18%-132.41K | 105.40%13.56K | -5,800.00%-57K | 66.98%-80.97K | 98.58%-8K | 66.42%-836.97K | 89.92%-250.97K | 542.48%1K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 990.74%970K | -114.05%-17K | -99.24%124.34K | 95.53%-12.76K | 12,400.00%125K | 59.51%-108.9K | -99.27%121K | -55.56%16.3M | -100.78%-285.44K | -59.17%1K |
| Net cash flow | ||||||||||
| Beginning cash position | -47.54%16.71M | -54.68%15.77M | 23.80%34.81M | -32.76%21.94M | -31.49%25.35M | -22.95%31.85M | 23.80%34.81M | 205.71%28.12M | 99,512.36%32.64M | 105,493.29%37M |
| Current changes in cash | 26.14%-3.89M | 111.37%528K | -614.37%-19.95M | -1,645.52%-6.25M | -10.94%-3.78M | -30.23%-5.27M | -139.64%-4.65M | -79.95%3.88M | -101.85%-357.86K | -129,694.52%-3.41M |
| Effect of exchange rate changes | 60.05%-495K | -75.83%408K | -67.48%914.94K | -96.52%88.1K | 139.54%378K | -336.73%-1.24M | 12.38%1.69M | 759.15%2.81M | 693.70%2.53M | -274,812.64%-956K |
| End cash Position | -51.38%12.32M | -47.54%16.71M | -54.68%15.77M | -54.68%15.77M | -32.76%21.94M | -31.52%25.34M | -22.95%31.85M | 23.80%34.81M | 23.80%34.81M | 99,512.36%32.64M |
| Free cash flow | 5.80%-4.86M | 111.44%545K | -61.29%-20.04M | -8,467.47%-6.2M | -14.57%-3.91M | -36.58%-5.16M | 2.62%-4.77M | 28.34%-12.43M | 99.58%-72.42K | -67,105.04%-3.41M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg